Stifel Financial
GPCR icon

Stifel Financial’s Structure Therapeutics GPCR Stock Holding History

Stifel Financial’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$807K Buy
15,032
+3,690
+33% +$163K ﹤0.01% 2689
2026
Q1 		$547K Buy
11,342
+6,512
+135% +$446K ﹤0.01% 2833
2025
Q4 		$336K Buy
+4,830
New +$197K ﹤0.01% 3085

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Stifel Financial's GPCR Position: Q2 2026 in Review

Stifel Financial increased its Structure Therapeutics (GPCR) stake by 33% in Q2 2026, buying an estimated $163K and bringing the position to 15,032 shares worth $807K. The position accounts for ﹤0.01% of the portfolio, ranked #2689.

Stifel Financial first reported a position in GPCR in Q4 2025 and has held it in 3 quarters since. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Stifel Financial held 15,032 shares of Structure Therapeutics worth $807K as of Q2 2026.
  • Stifel Financial bought 3,690 Structure Therapeutics shares in Q2 2026, an estimated $163K.
  • Structure Therapeutics made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #2689 holding.
  • Stifel Financial first reported a position in Structure Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.